Update from OBIO
Dear Member of the OBIO Community,
I am writing to provide an update to you about OBIO's response to COVID-19.
What we will be doing at OBIO to play our part in the collective response is the following:
OBIO will continue operating as usual and, effective Wednesday, March 18, the OBIO team will be working remotely until further notice.
Meetings between OBIO and our stakeholders will be taking place as scheduled using video-conferencing and tele-conferencing options in place of meeting in person but be assured that the OBIO team will continue to conduct business.
OBIO events that can be moved online and run remotely will continue to move ahead as scheduled.
Access to OBIO Member Resources, such as utilizing GlobalData and Pitchbook databases, will continue. Please email Sanie Rizvi for more details. Additionally, please use the OBIO Member online portal for complete access to all resources available to Members.
All OBIO operations remain ongoing and our programs continue to function so please reach out with questions and comments as you normally would. You will be hearing from members of the OBIO team to schedule meetings and calls as usual and we look forward to continue to working with you as you build your businesses and develop your innovative health science products.
As we continue to conduct regular business, please let us know if you have any questions at all. Please keep safe and we’ll see you on the other side.
Sincerely,
Gail Garland
President and CEO
OBIO (Ontario Bioscience Innovation Organization)